Cite

HARVARD Citation

    Mo, F. et al. (2019). Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer. Vaccine. 37 (7), pp. 926-936. [Online]. 
  
Back to record